FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease

Table 1

Basal characteristics of patients with Kawasaki disease (KD) and normal controls.

Characteristics	KD patients	Control subjects
Number of subjects	36^†	24
Gender: male (%)	25 (69.4%)	11 (45.8%)
Age (years)	1.57 ± 1.21	4.91 ± 2.78
Age range	0–5	1–11

The number included 13 IVIG-nonresponsive and 22 IVIG-responsive patients and 1 KD patient without record of using IVIG treatment.